Influenza vaccines for preventing cardiovascular disease.

@article{Clar2015InfluenzaVF,
  title={Influenza vaccines for preventing cardiovascular disease.},
  author={Christine Clar and Zainab Oseni and Nadine Flowers and Maryam keshtkar-Jahromi and Karen Rees},
  journal={The Cochrane database of systematic reviews},
  year={2015},
  volume={5},
  pages={
          CD005050
        }
}
BACKGROUND This is an update of the original review published in 2008. The risk of adverse cardiovascular outcomes is increased with influenza-like infection, and vaccination against influenza may improve cardiovascular outcomes. OBJECTIVES To assess the potential benefits of influenza vaccination for primary and secondary prevention of cardiovascular disease. SEARCH METHODS We searched the following electronic databases on 18 October 2013: The Cochrane Library (including Cochrane Central… 

Figures from this paper

Influenza vaccines for preventing cardiovascular disease.
  • J. Furtado
  • Medicine
    Sao Paulo medical journal = Revista paulista de medicina
  • 2015
TLDR
In patients with cardiovascular disease, influenza vaccination may reduce cardiovascular mortality and combined cardiovascular events, and results were not always consistent, so additional higher-quality evidence is necessary to confirm these findings.
Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies
TLDR
Influenza vaccination was associated with a significant decrease in all-cause mortality risk in patients with HF, and almost all evaluated outcomes had very low Grading of Recommendation, Assessment, Development and Evaluation evidence.
Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality
The association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis
TLDR
A living systematic review and a prospective meta-analysis are performed to evaluate the efficacy and safety of influenza vaccines compared to no vaccines or placebo for preventing mortality or cardiovascular disease events in the general population and in populations with pre-existing CVD.
Association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis
TLDR
A living systematic review and a prospective meta-analysis are performed to evaluate the efficacy and safety of influenza vaccines compared with no vaccines or placebo for preventing mortality or CVD events in the general population and in populations with pre-existing CVD.
Interventions to increase influenza vaccination rates of those 60 years and older in the community.
TLDR
This review updates versions published in 2010 and 2014 to assess access, provider, system, and societal interventions to increase the uptake of influenza vaccination in people aged 60 years and older in the community.
Seasonal influenza vaccination of high-risk adults
TLDR
This review examines, for each high-risk group, available data on influenza infection, vaccine efficacy and safety, and vaccine coverage from 2000 through 2015 on both seasonal and pandemic influenza.
Impact of Influenza Vaccination on All-Cause Mortality and Hospitalization for Pneumonia in Adults and the Elderly with Diabetes: A Meta-Analysis of Observational Studies
TLDR
The results of this meta-analysis are clinically relevant and support the recommendation for all persons with diabetes to receive influenza vaccination.
Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure
TLDR
The present review summarizes the current evidence and understanding for vaccination against influenza and streptococcus pneumoniae in CHD, HF and stroke and highlights its beneficial effect in the reduction of adverse cardiovascular events.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 75 REFERENCES
Influenza vaccines for preventing cardiovascular disease.
  • J. Furtado
  • Medicine
    Sao Paulo medical journal = Revista paulista de medicina
  • 2015
TLDR
In patients with cardiovascular disease, influenza vaccination may reduce cardiovascular mortality and combined cardiovascular events, and results were not always consistent, so additional higher-quality evidence is necessary to confirm these findings.
Vaccines for preventing influenza in healthy adults.
BACKGROUND Different types of influenza vaccines are currently produced worldwide. Vaccination of pregnant women is recommended internationally, while healthy adults are targeted in North America.
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.
TLDR
In a meta-analysis of RCTs, the use of influenza vaccine was associated with a lower risk of major adverse cardiovascular events and the greatest treatment effect was seen among the highest-risk patients with more active coronary disease.
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.
TLDR
In optimally treated CAD patients influenza vaccination improves the clinical course of CAD and reduces the frequency of coronary ischaemic events.
Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome.
TLDR
The influenza vaccine reduced major cardiovascular events in patients with ACS, and should be encouraged as a secondary prevention in this group of patients.
Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
TLDR
At least 60% of the patients achieved high post-vaccination antibody levels sufficient to prevent influenza, and the percentage of patients with significant post- vaccination concentrations of IgG and IgM was higher than before vaccination.
Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction
TLDR
Vaccination against influenza was negatively associated with the development of new MI during the same influenza season in patients with chronic CHD, however, to address causal inference, examination of prospective data sets will be needed.
Original paper The protective effect of influenza vaccination on the clinical course of coronary disease in patients with acute coronary syndromes treated by primary PCI – a report from FLUCAD study
TLDR
The protective effect of influenza vaccination on CAD clinical course was observed in patients with acute coronary syndrome but not in those with stable angina, suggesting Influenza vaccination may be safely performed immediately after ACS and primary PCI.
...
1
2
3
4
5
...